Skip to main content
. 2024 Mar 7;14(6):573. doi: 10.3390/diagnostics14060573

Table 2.

Histopathological classification.

Kalimuthu
Conventional Tubulopapillary Composite
Adsay
WHO Grade 1 Grade 2 Grade 3 Grade 1 Grade 2 Grade 3 Grade 1 Grade 2 Grade 3
Well differentiated 1 0 0 2 0 0 0 0 0
Moderately differentiated 9 1 1 6 1 0 3 1 3
Poorly differentiated 0 1 3 0 0 1 1 0 6

There were no Kalimuthu squamous tumors identified.